www.celonic.com
CEO of Swiss biologics CDMO Celonic, Konstantin Matentzoglu, explains how the company attracts talented and experienced staff and what makes it the partner of choice in Switzerland and beyond.
Celonic is in many ways more than a CDMO for biologics. What is the strategic focus of this company?
"Our focus is to engage with biopharmaceutical companies active in research and development stages and build long-term strategic partnerships where we handle the development of their products from the clinical stages through market-supply manufacturing."
